Bushen Jianpi Formula Combined with Entecavir for the Treatment of HBeAg-Negative Chronic Hepatitis B: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial

<div>HBV DNA suppression and alanine aminotransferase (ALT) normalization by visit week. (a) Proportion of patients with undetectable levels of HBV DNA by study visit. (b) Proportion of patients achieving ALT normalization by study visit.</div>

Evidence-Based Complementary and Alternative Medicine

fig4

Figure 4

Figure 4: Bushen Jianpi Formula Combined with Entecavir for the Treatment of HBeAg-Negative Chronic Hepatitis B: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial 

Figure 4 | Bushen Jianpi Formula Combined with Entecavir for the Treatment of HBeAg-Negative Chronic Hepatitis B: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial 